|
1
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krenning G, van Luyn MJ and Harmsen MC:
Endothelial progenitor cell-based neovascularization: Implications
for therapy. Trends Mol Med. 15:180–189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nathan DM, Cleary PA, Backlund JY, Genuth
SM, Lachin JM, Orchard TJ, Raskin P, Zinman B and Diabetes Control;
Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications (DCCT/EDIC) Study Research Group:
Intensive diabetes treatment and cardiovascular disease in patients
with type 1 diabetes. N Engl J Med. 353:2643–2653. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adeghate E: Molecular and cellular basis
of the aetiology and management of diabetic cardiomyopathy: A short
review. Mol Cell Biochem. 261:187–191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Federman DG, Bravata DM and Kirsner RS:
Peripheral arterial disease. A systemic disease extending beyond
the affected extremity. Geriatrics. 59:2629–30, 32 passim.
2004.PubMed/NCBI
|
|
6
|
Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C,
Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, et al: Evidence
for circulating bone marrow-derived endothelial cells. Blood.
92:362–367. 1998.PubMed/NCBI
|
|
7
|
Hristov M, Erl W and Weber PC: Endothelial
progenitor cells: Mobilization, differentiation, and homing.
Arterioscler Thromb Vasc Biol. 23:1185–1189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculo-genesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rafii S and Lyden D: Therapeutic stem and
progenitor cell transplantation for organ vascularization and
regeneration. Nat Med. 9:702–712. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chavakis E, Aicher A, Heeschen C, Sasaki
K, Kaiser R, El Makhfi N, Urbich C, Peters T, Scharffetter-Kochanek
K, Zeiher AM, et al: Role of beta2-integrins for homing and
neovascularization capacity of endothelial progenitor cells. J Exp
Med. 201:63–72. 2005. View Article : Google Scholar
|
|
11
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murasawa S and Asahara T: Endothelial
progenitor cells for vasculogenesis. Physiology (Bethesda).
20:36–42. 2005. View Article : Google Scholar
|
|
13
|
Iwami Y, Masuda H and Asahara T:
Endothelial progenitor cells: Past, state of the art, and future. J
Cell Mol Med. 8:488–497. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scheubel RJ, Zorn H, Silber RE, Kuss O,
Morawietz H, Holtz J and Simm A: Age-dependent depression in
circulating endothelial progenitor cells in patients undergoing
coronary artery bypass grafting. J Am Coll Cardiol. 42:2073–2080.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tepper OM, Galiano RD, Capla JM, Kalka C,
Gagne PJ, Jacobowitz GR, Levine JP and Gurtner GC: Human
endothelial progenitor cells from type II diabetics exhibit
impaired proliferation, adhesion, and incorporation into vascular
structures. Circulation. 106:2781–2786. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function, and cardiovascular risk. N
Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vasa M, Fichtlscherer S, Aicher A, Adler
K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valgimigli M, Rigolin GM, Fucili A, Porta
MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ,
Francolini G, Mauro E, et al: CD34+ and endothelial
progenitor cells in patients with various degrees of congestive
heart failure. Circulation. 110:1209–1212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murohara T, Ikeda H, Duan J, Shintani S,
Sasaki K, Eguchi H, Onitsuka I, Matsui K and Imaizumi T:
Transplanted cord blood-derived endothelial precursor cells augment
postnatal neovascularization. J Clin Invest. 105:1527–1536. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Madlambayan G and Rogers I: Umbilical
cord-derived stem cells for tissue therapy: Current and future
uses. Regen Med. 1:777–787. 2006. View Article : Google Scholar
|
|
21
|
Mayani H and Lansdorp PM: Thy-1 expression
is linked to functional properties of primitive hematopoietic
progenitor cells from human umbilical cord blood. Blood.
83:2410–2417. 1994.PubMed/NCBI
|
|
22
|
Cohen Y and Nagler A: Umbilical cord blood
transplantation -how, when and for whom? Blood Rev. 18:167–179.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rocha V, Wagner JE Jr, Sobocinski KA,
Klein JP, Zhang MJ, Horowitz MM and Gluckman E; Eurocord and
International Bone Marrow Transplant Registry Working Committee on
Alternative Donor and Stem Cell Sources: Graft-versus-host disease
in children who have received a cord-blood or bone marrow
transplant from an HLA-identical sibling. N Engl J Med.
342:1846–1854. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu E, Law HK and Lau YL: Tolerance
associated with cord blood transplantation may depend on the state
of host dendritic cells. Br J Haematol. 126:517–526. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
de La Selle V, Gluckman E and
Bruley-Rosset M: Newborn blood can engraft adult mice without
inducing graft-versus-host disease across non H-2 antigens. Blood.
87:3977–3983. 1996.PubMed/NCBI
|
|
26
|
Murohara T: Therapeutic vasculogenesis
using human cord blood-derived endothelial progenitors. Trends
Cardiovasc Med. 11:303–307. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang C, Zhang ZH, Li ZJ, Yang RC, Qian GQ
and Han ZC: Enhancement of neovascularization with cord blood
CD133+ cell-derived endothelial progenitor cell
transplantation. Thromb Haemost. 91:1202–1212. 2004.PubMed/NCBI
|
|
28
|
Senegaglia AC, Barboza LA, Dallagiovanna
B, Aita CA, Hansen P, Rebelatto CL, Aguiar AM, Miyague NI, Shigunov
P, Barchiki F, et al: Are purified or expanded cord blood-derived
CD133+ cells better at improving cardiac function? Exp
Biol Med (Maywood). 235:119–129. 2010. View Article : Google Scholar
|
|
29
|
Burger D, Viñas JL, Akbari S, Dehak H,
Knoll W, Gutsol A, Carter A, Touyz RM, Allan DS and Burns KD: Human
endothelial colony-forming cells protect against acute kidney
injury: Role of exosomes. Am J Pathol. 185:2309–2323. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo S, Yu L, Cheng Y, Li C, Zhang J, An J,
Wang H, Yan B, Zhan T, Cao Y, et al: PDGFRβ triggered by bFGF
promotes the proliferation and migration of endothelial progenitor
cells via p-ERK signalling. Cell Biol Int. 36:945–950. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wyler von Ballmoos M, Yang Z, Völzmann J,
Baumgartner I, Kalka C and Di Santo S: Endothelial progenitor cells
induce a phenotype shift in differentiated endothelial cells
towards PDGF/PDGFRβ axis-mediated angiogenesis. PloS One.
5:e141072010. View Article : Google Scholar
|
|
32
|
Zhang H, Bajraszewski N, Wu E, Wang H,
Moseman AP, Dabora SL, Griffin JD and Kwiatkowski DJ: PDGFRs are
critical for I3K/Akt activation and negatively regulated by mTOR. J
Clin Invest. 117:730–738. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Wang YC, Hu XB, Zhang BF, Dou GR,
He F, Gao F, Feng F, Liang YM, Dou KF and Han H: Notch-RBP-J
signaling regulates the mobilization and function of endothelial
progenitor cells by dynamic modulation of CXCR4 expression in mice.
PloS One. 4:e75722009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoder MC, Mead LE, Prater D, Krier TR,
Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT and Ingram DA:
Redefining endothelial progenitor cells via clonal analysis and
hematopoietic stem/progenitor cell principals. Blood.
109:1801–1809. 2007. View Article : Google Scholar
|
|
35
|
Lavergne M, Vanneaux V, Delmau C, Gluckman
E, Rodde-Astier I, Larghero J and Uzan G: Cord blood-circulating
endothelial progenitors for treatment of vascular diseases. Cell
Prolif. 44(Suppl 1): 44–47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moubarik C, Guillet B, Youssef B,
Codaccioni JL, Piercecchi MD, Sabatier F, Lionel P, Dou L,
Foucault-Bertaud A, Velly L, et al: Transplanted late outgrowth
endothelial progenitor cells as cell therapy product for stroke.
Stem Cell Rev. 7:208–220. 2011. View Article : Google Scholar
|
|
37
|
Kim J, Jeon YJ, Kim HE, Shin JM, Chung HM
and Chae JI: Comparative proteomic analysis of endothelial cells
progenitor cells derived from cord blood and peripheral blood for
cell therapy. Biomaterials. 34:1669–1685. 2013. View Article : Google Scholar
|
|
38
|
Kim SW, Jin HL, Kang SM, Kim S, Yoo KJ,
Jang Y, Kim HO and Yoon YS: Therapeutic effects of late outgrowth
endothelial progenitor cells or mesenchymal stem cells derived from
human umbilical cord blood on infarct repair. Int J Cardiol.
203:498–507. 2016. View Article : Google Scholar
|
|
39
|
Zhang Y, Li Y, Wang S, Han Z, Huang X, Li
S, Chen F, Niu R, Dong JF, Jiang R, et al: Transplantation of
expanded endothelial colony-forming cells improved outcomes of
traumatic brain injury in a mouse model. J Surg Res. 185:441–449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liang CJ, Shen WC, Chang FB, Wu VC, Wang
SH, Young GH, Tsai JS, Tseng YC, Peng YS and Chen YL: Endothelial
progenitor cells derived from Wharton's Jelly of human umbilical
cord attenuate ischemic acute kidney injury by increasing
vascularization and decreasing apoptosis, inflammation, and
fibrosis. Cell Transplant. 24:1363–1377. 2015. View Article : Google Scholar
|
|
41
|
Samsonraj RM, Raghunath M, Hui JH, Ling L,
Nurcombe V and Cool SM: Telomere length analysis of human
mesenchymal stem cells by quantitative PCR. Gene. 519:348–355.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gavard J and Gutkind JS: VEGF controls
endothelial-cell permeability by promoting the
beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol.
8:1223–1234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Taddei A, Giampietro C, Conti A, Orsenigo
F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S and
Dejana E: Endothelial adherens junctions control tight junctions by
VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol.
10:923–934. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Heupel WM, Efthymiadis A, Schlegel N,
Müller T, Baumer Y, Baumgartner W, Drenckhahn D and Waschke J:
Endothelial barrier stabilization by a cyclic tandem peptide
targeting VE-cadherin transinteraction in vitro and in vivo. J Cell
Sci. 122:1616–1625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Carmeliet P, Lampugnani MG, Moons L,
Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R,
Oosthuyse B, Dewerchin M, et al: Targeted deficiency or cytosolic
truncation of the VE-cadherin gene in mice impairs VEGF-mediated
endothelial survival and angiogenesis. Cell. 98:147–157. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Vittet D, Buchou T, Schweitzer A, Dejana E
and Huber P: Targeted null-mutation in the vascular
endothelial-cadherin gene impairs the organization of vascular-like
structures in embryoid bodies. Proc Natl Acad Sci USA.
94:6273–6278. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Crosby CV, Fleming PA, Argraves WS, Corada
M, Zanetta L, Dejana E and Drake CJ: VE-cadherin is not required
for the formation of nascent blood vessels but acts to prevent
their disassembly. Blood. 105:2771–2776. 2005. View Article : Google Scholar
|
|
48
|
Corada M, Mariotti M, Thurston G, Smith K,
Kunkel R, Brockhaus M, Lampugnani MG, Martin-Padura I, Stoppacciaro
A, Ruco L, et al: Vascular endothelial-cadherin is an important
determinant of microvascular integrity in vivo. Proc Natl Acad Sci
USA. 96:9815–9820. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Edirisinghe I and Rahman I: Cigarette
smoke-mediated oxidative stress, shear stress, and endothelial
dysfunction: Role of VEGFR2. Ann NY Acad Sci. 1203:66–72. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shalaby F, Rossant J, Yamaguchi TP,
Gertsenstein M, Wu XF, Breitman ML and Schuh AC: Failure of
blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature. 376:62–66. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Inoue A, Tanaka J, Takahashi H, Kohno S,
Ohue S, Umakoshi A, Gotoh K and Ohnishi T: Blood vessels expressing
CD90 in human and rat brain tumors. Neuropathology. 36:168–180.
2016. View Article : Google Scholar
|
